Rockefeller Capital Management’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.6M Sell
445,020
-296,332
-40% -$6.93M 0.02% 642
2026
Q1
$14.1M Buy
741,352
+35,489
+5% +$784K 0.03% 551
2025
Q4
$17.1M Sell
705,863
-304,266
-30% -$7.96M 0.03% 480
2025
Q3
$25.8M Sell
1,010,129
-16,286
-2% -$386K 0.05% 338
2025
Q2
$22.1M Buy
1,026,415
+62,158
+6% +$1.4M 0.05% 357
2025
Q1
$22M Buy
964,257
+142,493
+17% +$3.75M 0.05% 334
2024
Q4
$21.3M Buy
821,764
+236,267
+40% +$5.88M 0.06% 332
2024
Q3
$14.7M Buy
585,497
+262,504
+81% +$6.2M 0.04% 428
2024
Q2
$6.92M Buy
+322,993
New +$6.27M 0.02% 604
2023
Q1
Sell
-4,970
Closed -$90K 2200
2022
Q4
$90K Sell
4,970
-67
-1% -$1.38K ﹤0.01% 2083
2022
Q3
$114K Buy
5,037
+4,710
+1,440% +$101K ﹤0.01% 1921
2022
Q2
$4K Buy
327
+243
+289% +$3.57K ﹤0.01% 3506
2022
Q1
$1K Buy
+84
New +$2.21K ﹤0.01% 3701
2021
Q1
Sell
-33
Closed -$1K 3249
2020
Q4
$1K Buy
+33
New +$1.13K ﹤0.01% 2698

Other funds holding BLFS

Rockefeller Capital Management's BLFS Position: Q2 2026 in Review

Rockefeller Capital Management reduced its BioLife Solutions (BLFS) stake by 40% in Q2 2026, selling an estimated $6.93M and leaving 445,020 shares worth $12.6M. The position accounts for 0.02% of the portfolio, ranked #642.

Rockefeller Capital Management first reported a position in BLFS in Q4 2020 and has held it in 14 quarters since. The position peaked at $25.8M in Q3 2025. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Rockefeller Capital Management held 445,020 shares of BioLife Solutions worth $12.6M as of Q2 2026.
  • Rockefeller Capital Management sold 296,332 BioLife Solutions shares in Q2 2026, an estimated $6.93M.
  • BioLife Solutions made up 0.02% of Rockefeller Capital Management's portfolio in Q2 2026, its #642 holding.
  • Rockefeller Capital Management first reported a position in BioLife Solutions in Q4 2020 and has held it in 14 quarters since.
  • Rockefeller Capital Management's BioLife Solutions position peaked at $25.8M in Q3 2025.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.